GSK vs. VTI
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and Vanguard Total Stock Market ETF (VTI).
VTI is a passively managed fund by Vanguard that tracks the performance of the CRSP US Total Market Index. It was launched on May 24, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or VTI.
Correlation
The correlation between GSK and VTI is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GSK vs. VTI - Performance Comparison
Key characteristics
GSK:
-0.57
VTI:
2.14
GSK:
-0.68
VTI:
2.83
GSK:
0.92
VTI:
1.39
GSK:
-0.44
VTI:
3.26
GSK:
-0.93
VTI:
13.03
GSK:
13.53%
VTI:
2.14%
GSK:
22.07%
VTI:
13.09%
GSK:
-55.21%
VTI:
-55.45%
GSK:
-25.45%
VTI:
-1.75%
Returns By Period
In the year-to-date period, GSK achieves a -1.15% return, which is significantly lower than VTI's 2.20% return. Over the past 10 years, GSK has underperformed VTI with an annualized return of 1.93%, while VTI has yielded a comparatively higher 12.97% annualized return.
GSK
-1.15%
0.00%
-13.26%
-12.42%
-3.00%
1.93%
VTI
2.20%
2.33%
9.96%
26.84%
13.66%
12.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK vs. VTI — Risk-Adjusted Performance Rank
GSK
VTI
GSK vs. VTI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and Vanguard Total Stock Market ETF (VTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GSK vs. VTI - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 4.66%, more than VTI's 1.24% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.66% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
VTI Vanguard Total Stock Market ETF | 1.24% | 1.27% | 1.44% | 1.67% | 1.21% | 1.42% | 1.78% | 2.04% | 1.71% | 1.92% | 1.98% | 1.76% |
Drawdowns
GSK vs. VTI - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.21%, roughly equal to the maximum VTI drawdown of -55.45%. Use the drawdown chart below to compare losses from any high point for GSK and VTI. For additional features, visit the drawdowns tool.
Volatility
GSK vs. VTI - Volatility Comparison
GlaxoSmithKline plc (GSK) has a higher volatility of 5.97% compared to Vanguard Total Stock Market ETF (VTI) at 5.14%. This indicates that GSK's price experiences larger fluctuations and is considered to be riskier than VTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.